Life science companies always start with great scientific ideas or innovative medical solutions, but if they have not been protected properly, they cannot be seen through to execution. Developing a long-term intellectual property strategy is as important to develop early, alongside the the ideas that need protecting. The right IP strategy is multi-faceted and depends on the timing of innovation, source of the IP, potential applications and some creativity in what can be a competitive landscape.

Sally Shorthose, Partner, Bird & Bird
James Baillieu, Partner, Bird & Bird

The LSX channel features sessions from LSX events, where our mission is to connect senior #biotech, #medtech & #healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.

Subscribe to our channel for more videos.

Follow us on Twitter:   / lsxleaders  

Visit us at www.lsxleaders.com